Regular Article
Alternative Splicing of CYP2D mRNA in Human Breast Tissue

https://doi.org/10.1006/abbi.1997.0153Get rights and content

Abstract

The human cytochrome P450 (CYP) 2D subfamily comprises theCYP2D6gene and four pseudogenes,CYP2D7P1and2andCYP2D8P1and2.TheCYP2D6gene product is a prominent drug-metabolizing enzyme, which is probably constitutive and has no known inducing agents. Alternative splicing of the pre-mRNAs of these genes has been detected in human liver and breast tissue. RNA–PCR, competitive RNA–PCR, Southern blotting, cDNA sequencing, and gene-specific PCR have been used to fully characterize the alternatively spliced forms of CYP2D mRNA in human breast tissue in the region of exon 5 to 8. Such alternative splicing could regulate the expression of CYP2D6 protein. A full-length mRNA (exons 5 to 8), and variants c (exon 6 deleted), b′ (3′ portion of exon 6 deleted), e (3′ portion of exon 6 deleted, 3′ 57-bp portion of intron 6 included), d (3′ 57-bp portion of intron 6 included), and b (intron 6 included) were characterized and quantitated. Variant c was derived fromCYP2D6,variants d, e, and b were fromCYP2D7P,and variant b′ and full-length mRNA were derived from bothCYP2D6and2D7P.Full-length mRNA was a minor form in human breast tissue where variants b′ and c predominated. Human breast tumor MCF-7 cells had CYP2D mRNA splice variant patterns similar to those of human breast tissue, while human liver tumor HepG2 cells had wild-type mRNA predominating. These results suggest that CYP2D6 could be regulated tissue specifically using tissue-specific alternative mRNA splicing.

References (0)

Cited by (36)

  • DDPH, a novel antihypertensive agent, is a potential dual inhibitor of hepatic CYP2D and CYP3A

    2016, Chemico-Biological Interactions
    Citation Excerpt :

    Human CYP2D6 accounts for only roughly 5% of the total content of hepatic CYP, but is known to be responsible for the metabolism of about 20%–25% known drugs including methadone, verapamil and mexiletine [37]. In addition, only one isoform, CYP2D6, is expressed in various tissues in human [38]. The rat and human CYP2D isoforms possess a high sequence identity (>70%), and CYP2D1 is the rat homologue of human CYP2D6 [39].

  • Investigation of cytochrome P450 inhibitory properties of maslinic acid, a bioactive compound from Olea europaea L., and its structure-activity relationship

    2015, Phytomedicine
    Citation Excerpt :

    Human CYP2D6 enzyme is involved in the biotransformation of 30% of drugs on the market, although it is expressed at a low level in liver accounting for about 4% of total P450 (Madani et al. 1999). In addition, only one isoform, CYP2D6, is expressed in various tissues including the liver, kidney, placenta, brain, breast, lung and intestine in humans (Huang et al. 1997). The rat and human CYP2D isoforms share a high sequence identity (>70%), and CYP2D1 is the rat ortholog of human CYP2D6 (Venhorst et al. 2003).

  • Alternative splicing of vitamin D-24-hydroxylase: A novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis

    2005, Journal of Biological Chemistry
    Citation Excerpt :

    The ability of CYP24-SV to suppress synthesis of 1,25-(OH)2D was still evident at saturating doses of substrate. A possible explanation for this is that the splice variant functions in a noncatabolic fashion by competing with 1α-OHase for substrate, although alternative splicing in cytochrome P450 genes has previously been shown to cause changes in function, activity, substrate preference, and tissue specificity (43–46). Our current study is the first example of alternative splicing in CYP24 gene, although Neve et al. (40) have previously reported that deletion of 95 amino acids at the N terminus of the CYP2E1 protein abolished its mitochondrial targeting.

  • Inter-individual variation of several cytochrome P450 2D6 splice variants in human liver

    2005, Biochemical and Biophysical Research Communications
    Citation Excerpt :

    Variant b was later suggested to have derived from a pseudogene [14], and sequence alignment suggested that the previously observed variant b is probably CYP2D7P2 or CYP2D8P2. Authentic CYP2D6 transcript with intron 6 retained was subsequently observed in human breast tissue, the MCF-7 cell line, the HepG2 cell line, and normal human lung and lung tumor cells [15–17]. The variant a transcript originally observed in human liver also had the first base in exon 4 deleted; this deletion led to a shift in the reading frame.

View all citing articles on Scopus

Abbreviations used: CYP, cytochrome P450PCR, polymerase chain reaction; CE, capillary electrophoresis; DIG, digoxygenin; PM, poor metabolizer;

1

To whom correspondence and reprint requests should be addressed at Wadsworth Center, NYSDOH, P.O. Box 509, Albany, NY 12201-0509. Fax: 518-486-1505. E-mail: [email protected].

View full text